uniQure

$53.13
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$3.08 (-5.48%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell uniQure and other stocks, options, ETFs, and crypto commission-free!

About QURE

uniQure NV engages in the research, development, and commercialization of gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. Read More The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, the Netherlands.

Employees
212
Headquarters
Amsterdam, Noord-Holland
Founded
1998
Market Cap
2.00B
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
370.09K
High Today
$56.21
Low Today
$52.83
Open Price
$56.12
Volume
624.53K
52 Week High
$82.49
52 Week Low
$21.98

Collections

QURE Earnings

-$0.91
-$0.80
-$0.68
-$0.57
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected Nov 5, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.